Sfoglia per Rivista
Biodistribution and imaging of FDG in rats with LS174T carcinoma xenografts and focal Escherichia coli infection
2005-01-01 Kok, Pjm; van Eerd, Jem; Boerman, Oc; Corstens, Fhm; Oyen, W
Biodistribution of I-131-, Re-186-, Lu-177-, and Y-88-labeled hLL2 (epratuzumab) in nude mice with CD22-positive lymphoma
2003-01-01 Postema, Ej; Frielink, C; Oyen, W; Raemaekers, Jmm; Goldenberg, Dm; Corstens, Fhm; Boerman, Oc
Can Antibody Galactosylation Be Used to Improve Radioimmunotherapy of Induced Peritoneal Carcinomatosis of Colonic Origin in the Rat?
2009-01-01 Aarts, F; Hendriks, T; Eek, A; Oyen, W; Bleichrodt, Rp; Boerman, Oc
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study
2023-01-01 Bianchi, Andrea; De Rimini, Maria Luisa; Sciuto, Rosa; Annovazzi, Alessio; Di Traglia, Silvia; Bauckneht, Matteo; Lanfranchi, Francesco; Morbelli, Silvia; Nappi, Anna Giulia; Ferrari, Cristina; Rubini, Giuseppe; Panareo, Stefano; Urso, Luca; Bartolomei, Mirco; D'Arienzo, Davide; Valente, Tullio; Rossetti, Virginia; Caroli, Paola; Matteucci, Federica; Aricò, Demetrio; Bombaci, Michelangelo; Caponnetto, Domenica; Bertagna, Francesco; Albano, Domenico; Dondi, Francesco; Gusella, Sara; Spimpolo, Alessandro; Carriere, Cinzia; Balma, Michele; Buschiazzo, Ambra; Gallicchio, Rosj; Storto, Giovanni; Ruffini, Livia; Scarlattei, Maura; Baldari, Giorgio; Cervino, Anna Rita; Cuppari, Lea; Burei, Marta; Trifirò, Giuseppe; Brugola, Elisabetta; Zanini, Carolina Arianna; Alessi, Alessandra; Fuoco, Valentina; Seregni, Ettore; Deandreis, Désirée; Liberini, Virginia; Moreci, Antonino Maria; Ialuna, Salvatore; Pulizzi, Sabina; Evangelista, Laura
Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin
2006-01-01 Koppe, Mj; Oyen, W; Bleichrodt, Rp; Verhofstad, Aa; Goldenberg, Dm; Boerman, Oc
Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting
2002-01-01 Janssen, M; Oyen, W; Massuger, Lfag; Frielink, C; Dijkgraaf, I; Edwards, Ds; Radjopadhye, M; Corstens, Fhm; Boerman, Oc
Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: A phase III trial
2004-01-01 Oyen, W; Massuger, L; Verheijen, R; Seiden, M; Benigno, B; Lopes, A; Soper, J; Markowska, J; Vyzula, R; Lambert, H; Epenetos, A
Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer
2007-01-01 Oei, Alm; Massuger, Lfag; Oyen, W
Feasibility of Carbidopa Premedication in Pediatric Patients: A Pilot Study
2012-01-01 Lopci, Egesta; D'Ambrosio, Daniela; Nanni, Cristina; Chiti, A; Pession, Andrea; Marengo, Mario; Fanti, Stefano
Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin
2008-01-01 Aarts, F; Hendriks, T; Boerman, Oc; Oyen, W; Bleichrodt, Rp
Imaging expression of vascular endothelial growth factor (VEGF) in tumors with a radiolabeled anti-VEGF monoclonal antibody
2008-01-01 Boerman, Oc; Scheer, M; Stillebroer, A; Stollman, T; Leenders, W; Oostenwijk, E; Ruers, T; Mulders, P; Oyen, W
ImmunoPET Imaging of Renal Cell Carcinoma with I-124- and Zr-89-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice
2013-01-01 Stillebroer, Ab; Franssen, Gm; Mulders, Pfa; Oyen, W; van Dongen, Gams; Laverman, P; Oosterwijk, E; Boerman, Oc
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation
2004-01-01 Janssen, M; Frielink, C; Dijkgraaf, I; Oyen, W; Edwards, Ds; Liu, S; Rajopadhye, M; Massuger, L; Corstens, F; Boerman, O
Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma
2003-01-01 Brouwers, Ah; Frielink, C; Oosterwijk, E; Oyen, W; Corstens, Fhm; Boerman, Oc
Intracavitary radioimmunotherapy to treat solid tumors
2008-01-01 Aarts, F; Bleichrodt, Rp; Oyen, W; Boerman, Oc
Peptides for imaging infection and inflammation
2003-01-01 Oyen, W; Boerman, Oc; Rennen, Hjjm; Corstens, Fhm
PET radioimmunoscintigraphy of renal cell cancer using Zr-89-labeled cG250 monoclonal antibody in nude rats
2004-01-01 Brouwers, A; Verel, I; Van Eerd, J; Visser, G; Steffens, M; Oosterwijk, E; Corstens, F; Oyen, W; Van Dongen, G; Boerman, O
Pharmacokinetics and tumor targeting of I-131-labeled F(ab ')(2) fragments of the chimeric monoclonal antibody G250: Preclinical and clinical pilot studies
2004-01-01 Brouwers, A; Mulders, P; Oosterwijk, E; Buijs, W; Corstens, F; Boerman, O; Oyen, W
Pretargeted immunoPET imaging of CEA-expressing tumors using a Ga-68 labeled peptide
2008-01-01 Boerman, Oc; Sharkey, Rm; Chang, Ch; Rossi, Ea; Mcbride, W; Schoffelen, R; Oyen, W; Goldenberg, Dm
Pretargeted radioimmunotherapy of non-Hodgkin's lymphoma: Best of both worlds?
2000-01-01 Boerman, Oc; Oyen, W; Corstens, Fhm
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Biodistribution and imaging of FDG in rats with LS174T carcinoma xenografts and focal Escherichia coli infection | 1-gen-2005 | Kok, Pjm; van Eerd, Jem; Boerman, Oc; Corstens, Fhm; Oyen, W | |
Biodistribution of I-131-, Re-186-, Lu-177-, and Y-88-labeled hLL2 (epratuzumab) in nude mice with CD22-positive lymphoma | 1-gen-2003 | Postema, Ej; Frielink, C; Oyen, W; Raemaekers, Jmm; Goldenberg, Dm; Corstens, Fhm; Boerman, Oc | |
Can Antibody Galactosylation Be Used to Improve Radioimmunotherapy of Induced Peritoneal Carcinomatosis of Colonic Origin in the Rat? | 1-gen-2009 | Aarts, F; Hendriks, T; Eek, A; Oyen, W; Bleichrodt, Rp; Boerman, Oc | |
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study | 1-gen-2023 | Bianchi, Andrea; De Rimini, Maria Luisa; Sciuto, Rosa; Annovazzi, Alessio; Di Traglia, Silvia; Bauckneht, Matteo; Lanfranchi, Francesco; Morbelli, Silvia; Nappi, Anna Giulia; Ferrari, Cristina; Rubini, Giuseppe; Panareo, Stefano; Urso, Luca; Bartolomei, Mirco; D'Arienzo, Davide; Valente, Tullio; Rossetti, Virginia; Caroli, Paola; Matteucci, Federica; Aricò, Demetrio; Bombaci, Michelangelo; Caponnetto, Domenica; Bertagna, Francesco; Albano, Domenico; Dondi, Francesco; Gusella, Sara; Spimpolo, Alessandro; Carriere, Cinzia; Balma, Michele; Buschiazzo, Ambra; Gallicchio, Rosj; Storto, Giovanni; Ruffini, Livia; Scarlattei, Maura; Baldari, Giorgio; Cervino, Anna Rita; Cuppari, Lea; Burei, Marta; Trifirò, Giuseppe; Brugola, Elisabetta; Zanini, Carolina Arianna; Alessi, Alessandra; Fuoco, Valentina; Seregni, Ettore; Deandreis, Désirée; Liberini, Virginia; Moreci, Antonino Maria; Ialuna, Salvatore; Pulizzi, Sabina; Evangelista, Laura | |
Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin | 1-gen-2006 | Koppe, Mj; Oyen, W; Bleichrodt, Rp; Verhofstad, Aa; Goldenberg, Dm; Boerman, Oc | |
Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting | 1-gen-2002 | Janssen, M; Oyen, W; Massuger, Lfag; Frielink, C; Dijkgraaf, I; Edwards, Ds; Radjopadhye, M; Corstens, Fhm; Boerman, Oc | |
Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: A phase III trial | 1-gen-2004 | Oyen, W; Massuger, L; Verheijen, R; Seiden, M; Benigno, B; Lopes, A; Soper, J; Markowska, J; Vyzula, R; Lambert, H; Epenetos, A | |
Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer | 1-gen-2007 | Oei, Alm; Massuger, Lfag; Oyen, W | |
Feasibility of Carbidopa Premedication in Pediatric Patients: A Pilot Study | 1-gen-2012 | Lopci, Egesta; D'Ambrosio, Daniela; Nanni, Cristina; Chiti, A; Pession, Andrea; Marengo, Mario; Fanti, Stefano | |
Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin | 1-gen-2008 | Aarts, F; Hendriks, T; Boerman, Oc; Oyen, W; Bleichrodt, Rp | |
Imaging expression of vascular endothelial growth factor (VEGF) in tumors with a radiolabeled anti-VEGF monoclonal antibody | 1-gen-2008 | Boerman, Oc; Scheer, M; Stillebroer, A; Stollman, T; Leenders, W; Oostenwijk, E; Ruers, T; Mulders, P; Oyen, W | |
ImmunoPET Imaging of Renal Cell Carcinoma with I-124- and Zr-89-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice | 1-gen-2013 | Stillebroer, Ab; Franssen, Gm; Mulders, Pfa; Oyen, W; van Dongen, Gams; Laverman, P; Oosterwijk, E; Boerman, Oc | |
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation | 1-gen-2004 | Janssen, M; Frielink, C; Dijkgraaf, I; Oyen, W; Edwards, Ds; Liu, S; Rajopadhye, M; Massuger, L; Corstens, F; Boerman, O | |
Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma | 1-gen-2003 | Brouwers, Ah; Frielink, C; Oosterwijk, E; Oyen, W; Corstens, Fhm; Boerman, Oc | |
Intracavitary radioimmunotherapy to treat solid tumors | 1-gen-2008 | Aarts, F; Bleichrodt, Rp; Oyen, W; Boerman, Oc | |
Peptides for imaging infection and inflammation | 1-gen-2003 | Oyen, W; Boerman, Oc; Rennen, Hjjm; Corstens, Fhm | |
PET radioimmunoscintigraphy of renal cell cancer using Zr-89-labeled cG250 monoclonal antibody in nude rats | 1-gen-2004 | Brouwers, A; Verel, I; Van Eerd, J; Visser, G; Steffens, M; Oosterwijk, E; Corstens, F; Oyen, W; Van Dongen, G; Boerman, O | |
Pharmacokinetics and tumor targeting of I-131-labeled F(ab ')(2) fragments of the chimeric monoclonal antibody G250: Preclinical and clinical pilot studies | 1-gen-2004 | Brouwers, A; Mulders, P; Oosterwijk, E; Buijs, W; Corstens, F; Boerman, O; Oyen, W | |
Pretargeted immunoPET imaging of CEA-expressing tumors using a Ga-68 labeled peptide | 1-gen-2008 | Boerman, Oc; Sharkey, Rm; Chang, Ch; Rossi, Ea; Mcbride, W; Schoffelen, R; Oyen, W; Goldenberg, Dm | |
Pretargeted radioimmunotherapy of non-Hodgkin's lymphoma: Best of both worlds? | 1-gen-2000 | Boerman, Oc; Oyen, W; Corstens, Fhm |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile